HUTCHMED (China) (HCM) Cash & Equivalents (2014 - 2025)

HUTCHMED (China) (HCM) has 12 years of Cash & Equivalents data on file, last reported at $175.8 million in Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 100.0% year-over-year to $175.8 million in Q4 2025; TTM through Dec 2025 was $175.8 million, a 100.0% decrease from a year earlier, with the FY2025 full-year figure at $71.3 million, down 100.0% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $175.8 million, up from $110.7 million in the prior quarter.
• Over the last five years, Cash & Equivalents for HCM reached as high as $107549.6 billion in Q4 2024 and fell as low as $113433.7 in Q4 2023.
• Historically, Cash & Equivalents has averaged $9777.4 billion across 5 years, with a median of $204.0 million in 2024.
• Across the five-year window, Cash & Equivalents surged 94812718875.99% in 2024 and sank 100.0% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $129.9 million in 2021, then plunged by 37.89% to $80.7 million in 2022, then plunged by 99.86% to $113433.7 in 2023, then surged by 94812718875.99% to $107549.6 billion in 2024, then sank by 100.0% to $175.8 million in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $175.8 million in Q4 2025, $110.7 million in Q2 2025, and $107549.6 billion in Q4 2024.